Every spring, as school lunch tables are reorganised and families prepare for warmer months of travel and outdoor gatherings, food allergy awareness moves to the forefront of many parents’ minds. Food Allergy Awareness Week, typically observed in May, is the most prominent annual moment dedicated to education, safety, and empowerment for the more than 32 million Americans living with food allergies, according to Food Allergy Research & Education (FARE).
But awareness of food allergies has historically focused on emergency response — the epinephrine auto-injector, the importance of reading labels, the protocols for schools and restaurants. These are critical. They are also not the whole picture.
Behind every food allergic reaction is an immune process that can be measured. Understanding the biomarkers associated with allergic sensitisation gives individuals and families a more complete view of the biology at work — and a stronger foundation for the conversations they have with their healthcare providers.
What a Food Allergy Actually Is
The word “allergy” is used loosely in everyday conversation, applied to everything from rashes after eating strawberries to bloating after dairy. Clinically, however, a true food allergy refers to a specific type of immune response — and understanding the distinction matters for anyone trying to interpret their own health data meaningfully.
How IgE-Mediated Reactions Develop
Most food allergies that carry a risk of serious reactions are IgE-mediated, meaning they involve a class of antibodies called immunoglobulin E. Here is how this process unfolds.
On first exposure to a food protein — peanut, for example — the immune system may mistakenly identify it as a threat. In response, it produces allergen-specific IgE antibodies. These antibodies bind to the surface of immune cells called mast cells, which are distributed throughout the body’s tissues, particularly in the gut, skin, and airways. This initial phase is called sensitisation, and it typically occurs without any visible symptoms.
On subsequent exposures to the same protein, the allergen binds to the IgE antibodies already attached to mast cells. This triggers the mast cells to release a cascade of chemical mediators — most notably histamine — which produce the familiar symptoms of an allergic reaction: hives, itching, swelling, gastrointestinal distress, and in severe cases, anaphylaxis.
The critical point is that sensitisation and clinical allergy are not the same thing, a distinction that carries enormous practical importance when interpreting laboratory results.
Food Allergy vs. Food Intolerance
A food allergy involves the immune system. A food intolerance does not. This is the fundamental difference, and it affects everything from symptom severity to how the condition is managed.
Food intolerances — such as lactose intolerance, which results from insufficient production of the enzyme lactase — can cause significant discomfort, including bloating, cramping, and diarrhoea. They are not mediated by IgE, do not involve mast cell activation, and do not carry a risk of anaphylaxis. They may also be dose-dependent, meaning small amounts of the offending food are sometimes tolerated.
IgE-mediated food allergies, by contrast, can trigger reactions at very small exposures and can involve multiple body systems simultaneously. Some non-IgE-mediated immune responses to food also exist — such as food protein-induced enterocolitis syndrome (FPIES) — which fall between allergy and intolerance in clinical classification. These are less commonly tested via standard IgE panels and require specialist evaluation.
Why Food Allergy Awareness Week Matters
The Public Health Impact of Food Allergies
Food allergies represent a significant and growing public health issue. According to FARE, approximately one in ten adults and one in thirteen children in the United States has a food allergy. The nine most common allergens — peanuts, tree nuts, milk, eggs, wheat, soy, fish, shellfish, and sesame — account for the vast majority of reactions.
Anaphylaxis, the most severe form of allergic reaction, sends an estimated 200,000 people to emergency departments each year in the U.S. Food allergies also carry a substantial economic burden: FARE estimates the annual cost at more than $25 billion, including medical care, special foods, and lost productivity. Beyond statistics, the day-to-day management of food allergies affects social participation, mental health, and quality of life for millions of children and adults.
Who Is Most at Risk?
Children are disproportionately affected, with food allergies being most commonly diagnosed in the first years of life. A number of factors are associated with increased likelihood of developing food allergies. A family history of food allergy, asthma, or eczema is among the strongest predictors — reflecting the shared immunological terrain of the atopic triad. Children with eczema, in particular, have a significantly elevated risk of developing food allergies, likely due in part to altered skin barrier function that may allow allergenic proteins to enter the body through the skin before oral tolerance is established.
Race and ethnicity also appear to influence prevalence. Research has found higher rates of food allergy in Black and Hispanic children compared to white children, though the mechanisms are not yet fully understood. Socioeconomic factors affect both diagnosis rates and access to specialist care.
Key Biomarkers Linked to Food Allergy
When a healthcare provider is evaluating suspected food allergy, a set of specific laboratory tests can provide measurable data about immune activity. These are not the only tools used in allergy evaluation — clinical history and, in many cases, supervised oral food challenges remain essential — but they offer a valuable window into the immune system’s relationship with specific foods.
Allergen-Specific IgE — Identifying Sensitisation
Allergen-specific IgE testing measures the concentration of IgE antibodies directed at a particular food protein in the bloodstream. Tests are available for a wide range of individual allergens, including peanut, cow’s milk, hen’s egg, tree nuts (such as cashew, walnut, and hazelnut), wheat, soy, fish, and shellfish, among others.
Results are reported in kilounits per litre (kUA/L) and typically assigned to a standardised class — with Class 0 indicating very low or undetectable levels and higher classes reflecting progressively greater concentrations of allergen-specific IgE.
A key caveat: the level of allergen-specific IgE is associated with the likelihood of sensitisation, but it does not directly predict whether a clinical reaction will occur or how severe that reaction might be. Some individuals with relatively high IgE levels tolerate a food without symptoms, while others with lower levels experience significant reactions. This is why allergy testing is always interpreted within the context of a thorough clinical history.
A more refined approach, component-resolved diagnostics (CRD), tests for IgE reactivity to individual protein components within a food rather than the whole food extract. For peanut, for example, reactivity to the component Ara h 2 is associated with a higher likelihood of clinical reaction than reactivity to other components. CRD can provide more nuanced information to guide clinical decision-making, though it is typically used in specialist settings.
Total IgE and Atopic Tendency
Total IgE measures the overall concentration of IgE antibodies in the blood, regardless of their specific targets. Elevated total IgE is associated with atopic conditions — meaning conditions involving an overactive IgE-mediated immune response — including food allergy, allergic rhinitis (hay fever), allergic asthma, and atopic dermatitis (eczema).
Total IgE alone is not sufficient to diagnose a specific food allergy. Many factors can influence total IgE levels, including parasitic infections, certain medications, and even the season in which the test is taken. However, persistently elevated total IgE in an individual with symptoms of atopic disease can support clinical suspicion and prompt more specific testing.
For children, total IgE tends to rise through childhood, peaking in early adulthood before declining. Understanding where a child’s total IgE sits relative to age-adjusted reference ranges can contribute to the broader picture of their atopic risk profile.
Tryptase and Acute Reactions
Tryptase is an enzyme released by mast cells during activation. In the context of a severe allergic reaction or anaphylaxis, mast cells are triggered en masse, releasing large quantities of tryptase into the bloodstream. Serum tryptase levels typically peak 30 to 120 minutes after the onset of an anaphylactic reaction and return to baseline within several hours.
Tryptase measurement is used in clinical settings to retrospectively confirm that an acute reaction involved mast cell activation — helping distinguish anaphylaxis from other conditions that may present similarly, such as vasovagal episodes or panic attacks. It can also be useful in identifying individuals with mastocytosis, a condition involving an abnormal accumulation of mast cells that can elevate baseline tryptase and heighten sensitivity to allergic triggers.
Baseline tryptase, measured when an individual is well, is increasingly recognised as a useful reference point. Some research suggests that elevated baseline tryptase may be associated with more severe reactions in individuals with known allergies, though interpretation remains an evolving area of clinical research.
What Allergy Biomarkers Can (and Cannot) Tell You
Sensitisation vs. Clinical Allergy
This distinction cannot be overstated, and it is arguably the most important concept for anyone exploring allergy biomarkers to understand. A positive IgE result indicates sensitisation — it does not confirm a clinical allergy.
Sensitisation means the immune system has produced IgE antibodies against a specific food protein. Clinical allergy means that exposure to that food reliably produces symptoms. The two frequently coincide, but they are not the same thing. Population studies have consistently found that rates of sensitisation are significantly higher than rates of confirmed clinical allergy, particularly in children.
This means that an elevated peanut-specific IgE result in a child who has always eaten peanuts without any reaction does not, on its own, warrant dietary elimination. Conversely, a very low or undetectable IgE result does not definitively rule out an allergic tendency, particularly for non-IgE-mediated reactions.
The gold standard for confirming or ruling out a food allergy remains the physician-supervised oral food challenge (OFC), in which the individual consumes incremental doses of the suspected food under controlled conditions. This is performed in specialist settings with emergency equipment on hand — it is not something that should be attempted at home.
The Role of Clinical History and Physician Evaluation
Laboratory results are most meaningful when interpreted alongside a detailed account of the individual’s reaction history, medical background, and family history of atopy. A clinician — ideally an allergist or immunologist — integrates all of these inputs to determine the most appropriate next steps, which may include dietary avoidance, further specialist testing, or a supervised oral food challenge.
Biomarker literacy supports this process. Individuals who understand what their IgE levels represent are better equipped to ask informed questions, communicate their history clearly, and engage actively in shared decision-making with their care team.
Who May Benefit From Monitoring Allergy Biomarkers
Children With Eczema or Asthma
Children with moderate to severe atopic dermatitis (eczema) have a substantially elevated risk of developing IgE-mediated food allergies — a progression sometimes referred to as the atopic march. This term describes the tendency for atopic conditions to evolve over time, often beginning with eczema in infancy, followed by food allergy, and later allergic rhinitis and asthma.
For families managing childhood eczema or asthma, understanding allergen-specific IgE levels — particularly for common early-childhood allergens such as egg, milk, and peanut — may provide useful context for clinical conversations about dietary management and allergy monitoring.
Families With Allergy History
When a parent or sibling has a diagnosed food allergy, the likelihood that other family members may develop allergies is meaningfully elevated. Having a first-degree relative with a peanut allergy, for example, is associated with an approximately seven-fold increase in the risk of peanut allergy in siblings, according to research cited by FARE. Understanding one’s IgE profile in this context — while recognising the limitations of sensitisation data alone — can support proactive clinical engagement.
Adults With New or Changing Reactions
Food allergies are not exclusively a childhood phenomenon. Adult-onset food allergies are more common than many people realise. Shellfish and tree nut allergies, in particular, frequently develop in adulthood. Adults who notice new or changing reactions to foods — particularly recurring hives, gastrointestinal symptoms, or oral tingling — may find value in discussing allergen-specific IgE testing with their healthcare provider as a starting point for further evaluation.
It is also worth noting that food allergies can change over time in either direction. Some childhood allergies — particularly to milk and egg — are frequently outgrown, while others, such as peanut allergy, tend to persist. Serial IgE monitoring, conducted under clinical guidance, can contribute to decisions about whether a supervised oral food challenge might be appropriate.
Taking Ownership of Your Allergy Profile
How Direct-to-Consumer IgE Testing Works
Direct-to-consumer (DTC) lab testing has made allergen-specific IgE and total IgE testing more accessible to health-engaged individuals and families. After selecting a panel, a blood sample is collected at a certified local laboratory and results are delivered through a secure digital platform.
DTC allergy panels typically include allergen-specific IgE for common foods — peanut, tree nuts, milk, egg, wheat, and soy are among the most frequently requested. Total IgE may be included as a supporting marker. Results provide a personal data point that individuals can bring to a clinical consultation for professional interpretation.
It is essential to understand what DTC testing does and does not offer. It provides awareness and a starting point for conversation. It does not replace an allergist’s evaluation, does not confirm or exclude clinical allergy, and does not guide management decisions. Anyone who receives an elevated result and has questions should discuss those results with a qualified healthcare provider before making any dietary changes.
Tracking IgE Trends Over Time
One of the more valuable dimensions of biomarker monitoring is longitudinal observation — watching how levels change across time. For families managing known food allergies, periodic IgE monitoring can provide a personal data history that supports clinical discussions about whether an allergy may be resolving or evolving.
For individuals not yet under allergy specialist care but with risk factors such as family history or atopic conditions, tracking total IgE and selected allergen-specific IgE over time can help establish a personal baseline. When combined with clinical history and professional interpretation, this kind of data can make healthcare conversations more informed and more focused.
The Role of Awareness Weeks in Safer Living
Food Allergy Awareness Week exists because knowledge saves lives. The most immediate form of that knowledge — knowing how to recognise anaphylaxis, where the epinephrine is, how to communicate allergen needs in a restaurant or school — will always be the frontline priority.
But biomarker literacy is the layer beneath that. Understanding how the immune system becomes sensitised to food proteins, what IgE measures and what it does not, and how testing fits into a broader diagnostic process gives families and individuals a more complete picture of the biology they are navigating every day.
The goal is not to create anxiety about numbers or thresholds. It is to replace uncertainty with understanding — and to ensure that the conversations happening between patients and their healthcare providers are as informed and productive as possible.
This Food Allergy Awareness Week, consider what you know about your own or your family’s allergy profile. If there are unanswered questions, a clinical conversation with an allergist or your primary care provider is a meaningful next step. Bring your questions, your reaction history, and if you have biomarker data, bring that too. Proactive health ownership, in the context of food allergy, means staying engaged — calmly, consistently, and with as much information as possible.
This article is for educational purposes only and does not constitute medical advice. Food allergy symptoms, including signs of anaphylaxis, require immediate emergency medical attention — do not use biomarker data as a substitute for urgent care. All laboratory results should be interpreted by a qualified healthcare professional in the context of a full clinical and dietary history. Direct-to-consumer testing is a health awareness tool and does not diagnose, treat, or prevent any medical condition.
